Peptide Purity Testing: What HPLC and Mass Spec Results Actually Tell You

Every research peptide ships with a purity figure — "≥99%" being the industry benchmark — but that number is the output of two distinct analytical methods, each measuring something different. Understanding what HPLC and mass spectrometry actually test for makes a Certificate of Analysis far more informative than a single percentage on a page.

High-Performance Liquid Chromatography (HPLC)

HPLC separates the components of a sample by passing it through a column under high pressure, with different molecules eluting at different rates based on their chemical properties (typically hydrophobicity in reversed-phase HPLC, the standard method for peptides).

• ·The output is a chromatogram — a series of peaks plotted against retention time
• ·The target peptide should produce one large, sharp, symmetric peak
• ·Smaller peaks represent impurities: truncated sequences from incomplete synthesis, deletion or insertion errors, oxidized residues, or residual solvents
• ·Purity by HPLC is calculated as the area of the main peak divided by the total area of all peaks — a 99% HPLC purity means impurity peaks account for only 1% of total peak area

HPLC is excellent at quantifying purity but has a blind spot: it cannot tell you the identity of the main peak, only that whatever eluted at that retention time is dominant and clean-looking. A completely wrong peptide that happens to run as a single sharp peak would still show 99%+ HPLC purity.

Mass Spectrometry (MS)

Mass spectrometry closes that gap by measuring the mass-to-charge ratio of ionized molecules in the sample, confirming molecular identity rather than just relative abundance.

• ·The output is a spectrum showing peaks at specific mass-to-charge values
• ·The dominant peak should correspond to the expected molecular weight of the target peptide (often reported in Da, as seen on individual research peptide product pages)
• ·MS can detect sequence errors, incomplete deprotection, and other synthesis defects that shift molecular weight even when HPLC purity looks clean
• ·Combined LC-MS (liquid chromatography–mass spectrometry) runs both analyses simultaneously, correlating each HPLC peak with its molecular identity — the gold standard for peptide QC

Why Both Tests Matter Together

| Test | Confirms | Blind Spot |

|---|---|---|

| HPLC | Relative purity (% of total peak area) | Cannot confirm identity |

| Mass Spec | Molecular identity (correct compound) | Alone, doesn't quantify purity |

| LC-MS | Both purity and identity, correlated | Most comprehensive, higher cost |

A COA reporting only an HPLC trace tells you the vial contains one dominant substance at a stated purity — it does not, by itself, prove that substance is the labelled peptide. A COA reporting LC-MS or a matched HPLC + separate MS identity confirmation is the stronger standard to look for.

Reading a Chromatogram in Practice

When reviewing a COA's HPLC chromatogram, check for:

• ·Peak symmetry — a skewed or "fronting/tailing" peak can indicate column overload or sample degradation
• ·Baseline resolution — impurity peaks should be clearly separated from the main peak, not merged into its shoulder
• ·Retention time consistency — batch-to-batch retention time should be stable if synthesis and testing conditions are controlled

Practical Takeaway

A purity percentage without a visible chromatogram and, ideally, mass spec confirmation is a claim, not evidence. When evaluating a supplier, the Certificate of Analysis guide and the guide to choosing a research peptide supplier both cover what documentation to request before treating a purity figure as reliable.

Note: This article is provided for general research and educational purposes. JA Performance sells peptides strictly for laboratory and in vitro research use, not for human consumption.